Citation Impact
Citing Papers
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients
2006
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
2008 Standout
ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy
2013 StandoutNobel
S-Nitrosylation of β-Arrestin Regulates β-Adrenergic Receptor Trafficking
2008 StandoutNobel
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Sphingosine-1-phosphate signaling in the cardiovascular system
2007
Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting
2010
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet
2008
The clinical significance of endothelial dysfunction
2005
Purinergic Signaling in the Airways
2012
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids
2004
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Atheroprotective Effects of High-Density Lipoprotein-Associated Lysosphingolipids
2005
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
2020
Serum Creatinine: Not So Simple!
2017
Principles of bioactive lipid signalling: lessons from sphingolipids
2008 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Cholesterol, inflammation and innate immunity
2015
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
2014
Selenium and human health
2012 Standout
Macrophage death and defective inflammation resolution in atherosclerosis
2009
Nonresolving Inflammation
2010 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Prolonged Exposure to Sphingosine 1–Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury
2010
Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins
2008
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Acute kidney injury
2019 Standout
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
2004
FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier Function
2004
Identification of dinucleoside polyphosphates in adrenal glands
2003
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
2010 StandoutNature
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid – a position paper developed by the European Consensus Panel on HDL-C*
2004
The immunology of stroke: from mechanisms to translation
2011 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Dinucleoside polyphosphates and their interaction with other nucleotide signaling pathways
2006
Membrane lipids: where they are and how they behave
2008 Standout
Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/phosphodiesterases
2003
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
2006
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
2009
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
2007
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Endothelial Functions of Sphingosine-1-phosphate
2010
Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
2013
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
2013
Protective and pathogenic functions of macrophage subsets
2011 Standout
High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity
2005
Pyrimidine pathways in health and disease
2005
Current understanding of the metabolism and biological actions of HDL
2005
The Hallmarks of Aging
2013 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Calcium Signaling
2007 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
The acute respiratory distress syndrome
2012 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Estimating and measuring glomerular filtration rate
2014
HDL as a target in the treatment of atherosclerotic cardiovascular disease
2005
P2Y receptors and atherosclerosis in apolipoprotein E‐deficient mice
2009
Sphingosine 1-phosphate in coagulation and inflammation
2011
A Bench to Bedside View of Uremic Toxins
2008
Chronic Kidney Disease
2016 Standout
Clathrin‐Dependent Mechanisms of G Protein‐coupled Receptor Endocytosis
2007
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Phenylacetic Acid and Arterial Vascular Properties in Patients with Chronic Kidney Disease Stage 5 on Hemodialysis Therapy
2007
Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased
2013
NADPH oxidase in the vasculature: Expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension
2019
Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic Opportunities
2008
Prevalence and Characteristics of the Metabolic Syndrome in Women With Polycystic Ovary Syndrome
2005
HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
2008
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
High-Density Lipoproteins Induce Transforming Growth Factor-β 2 Expression in Endothelial Cells
2005
Decision aids for people facing health treatment or screening decisions
2017 Standout
Down‐regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice
2009
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
Immune and Inflammatory Mechanisms of Atherosclerosis
2009
Estimating Glomerular Filtration Rate in Older People
2014
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
2005
THE REGULATION AND PHARMACOLOGY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE
2005
HDL Cholesterol and Protective Factors in Atherosclerosis
2004
Mechanisms of Endocytosis
2009 Standout
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
The Sphingosine-1-Phosphate Analog FTY720 Reduces Muscle Ceramide Content and Improves Glucose Tolerance in High Fat-Fed Male Mice
2012
Physiology of Microglia
2011 Standout
Works of Markus Tölle being referenced
Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2
2010
Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells
2019
Immunomodulator FTY720 Induces Myofibroblast Differentiation via the Lysophospholipid Receptor S1P3 and Smad3 Signaling
2007
High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A
2012
Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor
2005
Paracrine stimulation of vascular smooth muscle proliferation by diadenosine polyphosphates released from proximal tubule epithelial cells
2007
Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans
2005
The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y2-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation
2011
Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification
2011
Effects of dinucleoside polyphosphates on regulation of coronary vascular tone
2002
Validation of the mobil-O-Graph: 24 h-blood pressure measurement device
2010
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression
2003
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
2004
Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure
2009
Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P 3
2005
The role of P2Y receptors in the control of blood pressure
2002
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption
2020
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression
2003
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
2004
Mass-Spectrometric Identification of a Novel Angiotensin Peptide in Human Plasma
2006
The Sphingosine-1-Phosphate Analogue FTY720 Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice
2006
Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older
2012
Arrestin-Independent Internalization and Recycling of the Urotensin Receptor Contribute to Long-Lasting Urotensin II–Mediated Vasoconstriction
2005
HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase-Dependent Monocyte Chemoattractant Protein-1 Production
2008